Assoc. Director for Clinical Innovations
Medicine
Timothy Judson, MD MPH
Associate Director of Clinical Innovations, Department of Medicine
Assistant Professor of Medicine, Division of Hospital Medicine
University of California, San Francisco
Dr. Judson is a hospital medicine and urgent care physician with expertise in digital health innovation and virtual care. Dr. Judson completed his MD at Weill Cornell Medical College in New York City, before joining UCSF for internal medicine residency, chief residency, and then a faculty position. As part of the UCSF Digital Patient Experience team, Dr. Judson designed and led the implementation of UCSF’s first self-triage and self-scheduling module in December 2019, before adapting that module to for COVID-19 in March 2020. He is the clinical product lead for the UCSF Employee Health Screener, which has been used to conduct over 400,000 daily symptom and exposure screens of UCSF employees since March 2020. He is the Lead Investigator at the UCSF site for the Track COVID study, which aims to enroll a random sample of 4,000 patients in the San Francisco Bay Area to determine the incidence and prevalence of COVID-19. His research and writing on COVID-19, health technologies, medical devices, high-value care and patient-physician communication have been featured in JAMA, JAMA Internal Medicine, BMJ, JAMIA and others.
Associate Director of Clinical Innovations, Department of Medicine
Assistant Professor of Medicine, Division of Hospital Medicine
University of California, San Francisco
Dr. Judson is a hospital medicine and urgent care physician with expertise in digital health innovation and virtual care. Dr. Judson completed his MD at Weill Cornell Medical College in New York City, before joining UCSF for internal medicine residency, chief residency, and then a faculty position. As part of the UCSF Digital Patient Experience team, Dr. Judson designed and led the implementation of UCSF’s first self-triage and self-scheduling module in December 2019, before adapting that module to for COVID-19 in March 2020. He is the clinical product lead for the UCSF Employee Health Screener, which has been used to conduct over 400,000 daily symptom and exposure screens of UCSF employees since March 2020. He is the Lead Investigator at the UCSF site for the Track COVID study, which aims to enroll a random sample of 4,000 patients in the San Francisco Bay Area to determine the incidence and prevalence of COVID-19. His research and writing on COVID-19, health technologies, medical devices, high-value care and patient-physician communication have been featured in JAMA, JAMA Internal Medicine, BMJ, JAMIA and others.